Tablet
NOSYSTOP Tablet product image
Bio-Availability
Tablet Format
Stability
24 Months
Grade
IP (Label)
Therapeutic Segment: Respiratory & Anti-Allergic

NOSYSTOP Tablet

“Relief from sneezing, itching & congestion”

NOSYSTOP is a tablet in Albarr Pharma's respiratory and anti-allergic range, combining montelukast, a leukotriene receptor antagonist, with levocetirizine, a second-generation antihistamine.

Dual-Ingredient Tablet

Montelukast (leukotriene receptor antagonist) with levocetirizine (second-generation H1-antihistamine).

Prescription Medicine

For use under the supervision of a registered medical practitioner.

Standard Packaging SKU:
10 × 10 Tablets
Primary Distribution:
Institutional, Hospital Dispensary & Ethical Retail
Enquire About This Product
Scientific Profile

Verified Product Composition

Declared composition as stated on Albarr Pharma's product material. Classifications and roles describe each ingredient in general.

Verified composition of NOSYSTOP
Active Constituent / Pharmacopoeia ReferenceClassificationDeclared QuantityTarget Action Profile
Montelukast SodiumReference pendingLeukotriene receptor antagonist10 mgBlocks cysteinyl leukotriene (CysLT1) receptors
Levocetirizine DihydrochlorideReference pendingSecond-generation H1-antihistamine5 mgBlocks histamine H1 receptors; the R-enantiomer of cetirizine

Ingredient roles are general reference descriptions, not product-specific claims. Pharmacopoeia references pending official documents.

Monograph Data

Technical Specifications

Official pharmaceutical handling instructions, storage protocols, and release parameters verified for distribution partners.

Storage Threshold

Store below 25°C in dry conditions

Blister Integrity

Alu-Alu tropical moisture barrier

Manufacturing License

WHO-GMP Compliant Manufacturing Facility

Product Description & Usage Intent

A prescription medicine supplied for use under the supervision of a registered medical practitioner. Indications, dosage and safety information are provided in the official product documentation.

  • Relieves Sneezing
  • Reduces Nasal Congestion
  • Controls Itching
  • Manages Allergy Symptoms

Storage, Stability & Preservation

Store as directed on the product label.

Packaging Specifications

Primary Packaging
Silver Alu-Alu Blister with tamper-evident seal
Secondary Box
Laminated Monocarton with anti-counterfeit foil
Shipper Standard
Corrugated Master Carton (40 Boxes / Shipper)
Synchronized Formulations

Complementary Products

View All Formulations
  • TAB
    MAXHEAL Tablet product image

    MAXHEALTAB

    “Triple action against pain, inflammation & fever”

    Composition:

    Diclofenac Potassium 50mg, Paracetamol 325mg, Serratiopeptidase 15mg

    View Details for MAXHEAL
  • Soft Gel Cap
    ABCORE Soft Gel Capsule product image

    ABCORE

    “Nutrition that keeps you going”

    Composition:

    Ginseng Extract Powder, Vitamin C, Vitamin E Acetate, Niacinamide, Calcium Pantothenate, Vitamin B2 (Riboflavin), Vitamin B1 (Thiamine), Vitamin B6 (Pyridoxine), Vitamin A Palmitate

    View Details for ABCORE
Institutional Distribution & PCD Franchise

Interested in Partnering or Ordering NOSYSTOP?

Connect with our regulatory supply division for commercial batch inquiries, wholesale distribution rights, and clinical documentation packages.